RT Journal Article
SR Electronic
T1 608 Results of a phase 1 study investigating camidanlumab tesirine as monotherapy and in combination with pembrolizumab in patients with selected advanced solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A692
OP A692
DO 10.1136/jitc-2023-SITC2023.0608
VO 11
IS Suppl 1
A1 Chen, Christopher T
A1 Hamilton, Erika
A1 LoRusso, Patricia
A1 Rottey, Sylvie
A1 Papadopoulos, Kyriakos P
A1 Kummar, Shivaani
A1 Kotecki, Nuria
A1 Thistlethwaite, Fiona C
A1 LeBruchec, Yvan
A1 Dyczkowski, Jerzy
A1 Rüschoff, Josef
A1 Samari, Sara
A1 Toukam, Marie
A1 Boni, Joseph
A1 Havenith, Karin
A1 Pantano, Serafino
A1 Puzanov, Igor
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A692.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.